Alpha Teknova Prepares for Financial Announcement
Alpha Teknova, Inc. (NASDAQ: TKNO), recognized for creating essential reagents vital to developing innovative therapies and diagnostics, is set to disclose its financial outcomes for the fourth quarter and the entire year concluding December 31, 2024. The announcement will occur on March 4, following the market's closing hours.
Engagement Through Webcast
On the same day, Teknova will facilitate a webcast alongside a conference call starting at 5 p.m. Eastern Time. This session will offer valuable insights into the company’s financial standing and future direction. Interested listeners can easily join the live event through the Investor Relations section of the Teknova website.
What to Expect from the Conference Call
During this conference call, Teknova's leadership will lay out crucial information regarding the financial performance and future strategies of the company. Participants are encouraged to register in advance to secure a unique PIN number and dial-in information. The recorded version of the webcast will be accessible on the company's website roughly two hours following the live airing.
Insights on Teknova's Vision
Founded in 1996, Teknova dedicates itself to enhancing life sciences through the production of critical reagents. Their multifaceted approach supports the development of groundbreaking therapies and diagnostics aimed at improving health outcomes worldwide. By providing customizable solutions tailored to every workflow phase, Teknova strengthens partnerships with industry leaders across various fields, including molecular diagnostics and synthetic biology.
Commitment to Quality and Innovation
Currently operating from a facility spread over 180,000 square feet, Teknova has designed a modular manufacturing framework that facilitates the efficient production of fundamental ingredients necessary for therapeutic advancements. This infrastructure, supported by a dedicated team of scientists, engineers, and quality control personnel, ensures the rapid turnaround of high-quality products, including agar plates and microbial culture media.
Meet the Team Behind Teknova
Matt Lowell, the Chief Financial Officer, leads the company's financial strategy and reporting efforts. He is committed to maintaining transparency and communication with stakeholders throughout each financial cycle. For inquiries, investors can reach out via email to Matt at the provided contact information.
Media Relations and Marketing Insights
Jennifer Henry, the Senior Vice President of Marketing, oversees the outreach and marketing strategies. Her responsibilities include ensuring that Teknova's advancements and product offerings are effectively communicated to the industry and the public.
Frequently Asked Questions
When will Teknova announce its financial results?
Teknova will announce its financial results on March 4, 2025.
How can I participate in the conference call?
You can participate by registering for the webcast through Teknova's Investor Relations section and obtaining a unique PIN.
What does Teknova specialize in?
Teknova specializes in the production of critical reagents for therapy development, diagnostics, and molecular biology.
Who can I contact for investor relations?
For investor inquiries, please contact Matt Lowell, CFO, via email.
Is the webcast available for replay?
Yes, the webcast will be available for replay on Teknova's website approximately two hours after the live presentation.
